[HTML] nih.gov

[HTML][HTML] BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

C Alvarez, T Tapia, E Perez-Moreno… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Identifying founder mutations in BRCA1 and BRCA2 in specific populations constitute a
valuable opportunity for genetic screening. Several studies from different populations have …
被引用次数：49 相关文章
[PDF] semanticscholar.org

[PDF][PDF] BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

C Alvarez, T Tapia, E Perez-Moreno… - pdfs.semanticscholar.org
Identifying founder mutations in BRCA1 and BRCA2 in specific populations constitute a
valuable opportunity for genetic screening. Several studies from different populations have …
[HTML] oncotarget.com

[HTML][HTML] BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

C Alvarez, T Tapia, E Perez-Moreno… - Oncotarget, 2017 - oncotarget.com
BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary
breast cancer families in Chile | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home …
[PDF] researchgate.net

[PDF][PDF] BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

C Alvarez, T Tapia, E Perez-Moreno… - researchgate.net
Identifying founder mutations in BRCA1 and BRCA2 in specific populations constitute a
valuable opportunity for genetic screening. Several studies from different populations have …

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.

C Alvarez, T Tapia, E Perez-Moreno… - Oncotarget, 2017 - europepmc.org
Identifying founder mutations in BRCA1 and BRCA2 in specific populations constitute a
valuable opportunity for genetic screening. Several studies from different populations have …

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.

C Alvarez, T Tapia, E Perez-Moreno… - Oncotarget, 2017 - escholarship.org
Identifying founder mutations in BRCA1 and BRCA2 in specific populations constitute a
valuable opportunity for genetic screening. Several studies from different populations have …
[PDF] academia.edu

[PDF][PDF] BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

C Alvarez, T Tapia, E Perez-Moreno… - academia.edu
Identifying founder mutations in BRCA1 and BRCA2 in specific populations constitute a
valuable opportunity for genetic screening. Several studies from different populations have …

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

C Alvarez, T Tapia, E Perez-Moreno… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Identifying founder mutations in BRCA1 and BRCA2 in specific populations constitute a
valuable opportunity for genetic screening. Several studies from different populations have …

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.

C Alvarez, T Tapia, E Perez-Moreno… - Oncotarget, 2017 - europepmc.org
Identifying founder mutations in BRCA1 and BRCA2 in specific populations constitute a
valuable opportunity for genetic screening. Several studies from different populations have …
[PDF] academia.edu

[PDF][PDF] BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

C Alvarez, T Tapia, E Perez-Moreno… - academia.edu
Identifying founder mutations in BRCA1 and BRCA2 in specific populations constitute a
valuable opportunity for genetic screening. Several studies from different populations have …